CHICAGO IL, USA -- /PRNewswire/ -- ICAP Ocean Tomo has been engaged to sell a patent portfolio of near-infrared spectroscopy technology owned by NIResults Inc.

The portfolio includes over 90 issued US and foreign patents and patent applications. The assets have been cited by over 20 companies including Abbott Laboratories, Baxter International, Bayer Healthcare, Beckman Coulter Inc., Xerox, and Hewlett Packard.

The patents of this portfolio cover the use of near-infrared spectroscopy in clinical chemistry analysis systems, pulse oximeters and CO-oximeters, non-invasive glucose monitors, and hemoglobin monitors. The patents describe a method for the monitoring of key blood analytes without the need for costly, environmentally challenging, chemical reagents.

The assets also include in-vitro, which is applied to a droplet of blood from a sample, and in-vivo (non-invasive) technology, which does not require a blood sample.

Using near-infrared spectroscopy technology to count analytes in the blood eliminates the disadvantages associated with conventional methods such as the risk of patient infection and discomfort from invasive sampling methods and erroneous test results due to time delays between when the blood is drawn and analyzed.

"This portfolio will provide the purchaser with the coverage necessary to develop next generation monitoring devices," said Dean Becker, ICAP Ocean Tomo CEO. This portfolio should be of interest to any entity involved in diabetes management or blood monitoring markets, or developing products for analyte measurement.

To learn more about the patents available for sale in this portfolio or how to sell or buy intellectual property please contact ICAP Ocean Tomo at 1 866-779-8363 or at patent.brokerage@us.icap.com.

About ICAP Ocean Tomo LLC

ICAP Ocean Tomo is the intellectual property brokerage division of ICAP.

About ICAP

ICAP is the world's premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP is also the source of global market information and research for professionals in the international financial markets. ICAP plc was added to the FTSE 100 Index on 30 June 2006.

For more information go to www.icap.com

RELATED LINK
www.icapoceantomo.com